11 results for author:"Olsen S.K." in Literature citations
Results Customize
› Repeat search in UniProtKB (20)
| Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1. Beenken A., Eliseenkova A.V., Ibrahimi O.A., Olsen S.K., Mohammadi M. J. Biol. Chem. 287:3067-3078(2012) · Mapped (7) |
| No requirement of trans presentations of IL-15 for human CD8 T cell proliferation. Ota N., Takase M., Uchiyama H., Olsen S.K., Kanagawa O. J. Immunol. 185:6041-6048(2010) · Mapped (6) |
| Active site remodelling accompanies thioester bond formation in the SUMO E1. Olsen S.K., Capili A.D., Lu X., Tan D.S., Lima C.D. |
| Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix. Kalinina J., Byron S.A., Makarenkova H.P., Olsen S.K., Eliseenkova A.V., Larochelle W.J., Dhanabal M., Blais S., Ornitz D.M., Day L.A. et al. Mol. Cell. Biol. 29:4663-4678(2009) · UniProtKB (1) · Mapped (2) |
| Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation. Olsen S.K., Ota N., Kishishita S., Kukimoto-Niino M., Murayama K., Uchiyama H., Toyama M., Terada T., Shirouzu M., Kanagawa O. et al. J. Biol. Chem. 282:37191-37204(2007) · UniProtKB (2) |
| Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Goetz R., Beenken A., Ibrahimi O.A., Kalinina J., Olsen S.K., Eliseenkova A.V., Xu C., Neubert T.A., Zhang F., Linhardt R.J. et al. Mol. Cell. Biol. 27:3417-3428(2007) · UniProtKB (2) |
| Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M., Ornitz D.M. J. Biol. Chem. 281:15694-15700(2006) · UniProtKB (16) · Mapped (2) |
| Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Olsen S.K., Li J.Y.H., Bromleigh C., Eliseenkova A.V., Ibrahimi O.A., Lao Z., Zhang F., Linhardt R.J., Joyner A.L., Mohammadi M. |
| Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization. Ibrahimi O.A., Yeh B.K., Eliseenkova A.V., Zhang F., Olsen S.K., Igarashi M., Aaronson S.A., Linhardt R.J., Mohammadi M. Mol. Cell. Biol. 25:671-684(2005) · Mapped (4) |
| Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Olsen S.K., Ibrahimi O.A., Raucci A., Zhang F., Eliseenkova A.V., Yayon A., Basilico C., Linhardt R.J., Schlessinger J., Mohammadi M. Proc. Natl. Acad. Sci. U.S.A. 101:935-940(2004) · UniProtKB (2) |
| Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs. Olsen S.K., Garbi M., Zampieri N., Eliseenkova A.V., Ornitz D.M., Goldfarb M., Mohammadi M. J. Biol. Chem. 278:34226-34236(2003) · Mapped (10) |